IM Cannabis (IMCC) Research & Development (2020 - 2026)

IM Cannabis' Research & Development history runs 7 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• On a quarterly basis, Research & Development rose 25.43% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $3.9 million, a 9.81% decrease from a year earlier, with the FY2024 full-year figure at $5.2 million, down 35.43% from the prior year.
• Research & Development improved to $1.1 million in Q1 2026 per IMCC's latest filing, from $997669.9 in the prior quarter.
• Across five years, Research & Development topped out at $2.4 million in Q2 2022 and bottomed at $887174.7 in Q1 2025.
• The 5-year median for Research & Development is $1.5 million (2024), against an average of $1.6 million.
• Across the five-year window, Research & Development jumped 131.21% in 2022 and tumbled 47.84% in 2025, its largest moves.
• Year by year, Research & Development stood at $2.3 million in 2022, then retreated by 9.87% to $2.1 million in 2023, then slumped by 37.63% to $1.3 million in 2024, then retreated by 22.14% to $997669.9 in 2025, then increased by 11.54% to $1.1 million in 2026.
• Per Business Quant, the three latest IMCC Research & Development figures stand at $1.1 million (Q1 2026), $997669.9 (Q3 2025), and $930287.4 (Q2 2025).